focus -WSS

focus

author：fashion 2025-08-26 10:53:03 - browse：9837

Blood corpuscles in clot — Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success. David Gregory & Debbie Marshall/Wellcome Images

Vascular device maker Inari Medical announced plans to buy LimFlow, a company selling a last-line therapy to save legs with blocked blood flow, on Wednesday. Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success.

LimFlow recently snagged Food and Drug Administration approval for its surgical system that uses a stent to connect a blocked artery to an open vein, thus allowing blood to flow through and heal injuries. The tool is meant only for patients with a severe form of peripheral artery disease, and who have already tried more conservative options.

Dan Rose, CEO of LimFlow, previously told STAT that his mission is to fight the amputation epidemic in the United States, which disproportionately impacts Black patients. Experts cautioned to STAT that expanding screenings to catch the disease early is still the most important measure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Radiation, mainstay of cancer treatment, begins a fade

WSS

AstraZeneca bets AAV gene therapy will still deliver the goods

Adele warns fans about throwing things at performers onstage

How to make AI work for medicine

CDC advisory panel says seniors 'may' get RSV vaccine

Princess Kate attends Wimbledon with Roger Federer: See the photos

Pentagon will tighten controls on classified information after Discord leak

entertainment

focus

knowledge

After affirmative action ruling, medical educators look to 'holistic review'

The leaders of Italy and Poland say European Union should focus on stopping migration

Virginia high school admissions case could be legal follow

EU moves toward latest gene techniques in food production to counter climate change, shortages

Novavax promises a turnaround & Lilly roils the obesity market

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

Bright Health sells Medicare Advantage business to Molina

Study finds new variant for Parkinson’s in African populations

leisure time

Study finds new variant for Parkinson’s in African populations

Gov. Ron DeSantis' push for 'civics' education: What does it look like?

Man with guns arrested near Obama home 'attempted to evade' Secret Service: Prosecutors

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

Feds fine Medicare Advantage plans for overcharging members

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

knowledge

hotspot

focus

leisure time